Skip to main content
Fig. 7 | BMC Microbiology

Fig. 7

From: The potential of Klebsiella and Escherichia-Shigella and amino acids metabolism to monitor patients with postmenopausal osteoporosis in northwest China

Fig. 7

Metabolite markers for pairwise discriminations of OST, LBM and N groups. A Receiver operating characteristic (ROC) analysis for the 6 metabolite markers discriminating LBM from N in negetive model. B Area under the curve (AUC) applying the 6 LBM vs N metabolite markers to discriminate LBM from N in negetive model. C AUC value of metabolite of Xanthine discriminating LBM from N in negetive model. D AUC value of metabolite of Sulfamerazine discriminating LBM from N in negetive model. E ROC analysis for the 6 metabolite markers discriminating LBM from N in positive model. F AUC applying the 6 LBM vs N metabolite markers to discriminate LBM from N in positive model. G AUC value of metabolite of 7-ketodeoxycholic acid discriminating LBM from N in positive model. H AUC value of metabolite of indole-3-acetic acid discriminating LBM from N in positive model. I ROC analysis for the 6 metabolite markers discriminating OST from N in negetive model. J AUC applying the 6 OST vs N metabolite markers to discriminate OST from N in negetive model. K AUC value of metabolite of Aminolevulinic discriminating OST from N in negetive model. L AUC value of metabolite of Phosphoarginine discriminating OST from N in negetive model. M ROC analysis for the 6 metabolite markers discriminating OST from N in positive model. N AUC applying the 6 OST vs N metabolite markers to discriminate OST from N in positive model. O)AUC value of metabolite of L-Phenylalanine discriminating OST from N in positive model. P AUC value of metabolite of L-proline discriminating OST from N in positive model. LBM: Lower bone mass, OST: osteoporosis, N: Normal group

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us